The anti-insomnia drug Dali Lesheng was launched on Ali Health
September 5, 2025
Source: drugdu
130
September 4th that Dalirexant (trade name: Covitra), a global next-generation insomnia drug introduced by Simcere Pharmaceuticals, officially launched on Alibaba Health . Currently, Dalirexant is the only DORA (dual orexin receptor antagonist)-class insomnia drug approved by the European Medicines Agency to improve daytime function. Originating in Switzerland, it was jointly developed and introduced by Simcere Pharmaceuticals and Idorsia. The drug has previously been approved for marketing in 11 countries, including the United States, the United Kingdom, Switzerland, Japan, Canada, and Hong Kong. (21st Century Business Herald)
https://finance.eastmoney.com/a/202509043505017121.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
